Examine guidelines for establishment registration and listing. Review standards forf inspections, how to determine when a product is considered adulterated, and current Good Manufacturing practices (cGMPs). Discuss the scope of pre-license and pre-approval inspections (PAIs). Examine FDA’s inspection authority and its enforcement process.
Scott Kaplan, Counsel, Hogan Lovells US LLP
This session was recorded as part of FDLI’s Virtual Introduction to Biologics and Biosimilars Laws and Regulations Course in March 2021.